Vol 48 No 7

Are phase 3 HERO results a game-changer for urologists?

Oral gonadotropin-releasing hormone receptor antagonist shows benefits

Is low-intensity surveillance feasible for patients with high-risk NMIBC?

BPH catheter system shows encouraging outcomes in pilot trial

Gene-mediated therapy for high-grade NMIBC delivers positive results in trial

What has been the telemedicine experience in urology during the COVID-19 pandemic?

How to fill the gap between retirement, Social Security

HIFU in focus: An expert's take on high-intensity focused ultrasound

Relugolix emerges as "exciting" new treatment in prostate cancer

Testosterone levels show steady decrease among young US men

Rechargeable neuromodulation system safe and efficacious through 1 year

It’s time to prepare for upcoming E/M coding changes

Photoselective vaporization of the prostate found safe, durably effective